Propranolol reduces sarcoma growth and enhances the response to anti-CTLA4 therapy by modulating the tumor microenvironment
K. Y. Fjaestad, A. M. Askehoj Romer, V. Goitea, A. Zedlitz Johansen, M.-L. Thorseth, M. Carretta, L. Henning Engelholm, L. Grontved, N. Junker, D. Hargbol Madsen
This study shows propranolol reduces sarcoma growth and enhances anti-CTLA4 therapy by modulating the tumor microenvironment through reduced angiogenesis and increased T cell infiltration.
bioRxiv · Mar 11, 2021 · PreprintCancer Biology